Growth factors and cytokines activate signal transduction pathways and regulate gene expression in eukaryotes. Intracellular domains of activated receptors recruit several protein kinases as well as transcription factors that serve as platforms or hubs for the assembly of multi-protein complexes. The signaling hubs involved in a related biologic function often share common interaction proteins and target genes. This functional connectivity suggests that a pairwise comparison of protein interaction partners of signaling hubs and network analysis of common partners and their expression analysis might lead to the identification of critical nodes in cellular signaling. A pairwise comparison of signaling hubs across several related pathways might also reveal novel signaling modules. Analysis of Protein Interaction Connectome by Venn (PIC-VENN) of transcription factors STAT1, STAT3, NFKB1, RELA, FOS and JUN, and their common interaction network suggested that BRCA1 and TSC22D3 function as critical nodes in immune responses by connecting the signaling nodes into signaling modules. Mutations or differential expression levels of these critical nodes in pathological conditions might deregulate signaling pathways and their target genes involved in inflammation. Biological connectivity emerges from the structural connectivity of interaction networks across several signaling hubs in related pathways. Application of PIC-VENN to several signaling hubs might reveal novel nodes and modules that can be targeted to simultaneously activate or inhibit cell signaling in health and disease.
Introduction
Signal transduction in mammalian cells is mediated through specific membrane receptors and intracellular kinases to regulate gene expression [1] . Ligand binding activates receptor tyrosine kinases (RTKs) activity by auto-phosphorylation or by serving as a substrate for other tyrosine kinases [2] .
Receptor phosphorylation can occur at several sites and induce modifications that stimulates intrinsic enzyme activity or establish docking positions for adaptor proteins that recognize phosphorylated tyrosine residues. In turn, tyrosine RTKs phosphorylate other substrates, thereby initiating a cascade of downstream signals including activation of Serine/Threonine protein kinases and multiple transcription factors. Several enzyme cascades consisting of mitogen-activated protein kinases (MAPK) and stressactivated protein kinases (SAPK) play critical roles in animal development as well as immune responses to pathogens [3] . Protein kinases, and transcription factors can serve as critical hubs or platforms for the assembly of signaling molecules [1] [2] [3] . Precision medicine requires the identification of molecular defects in human genetic diseases at the individual and gene-specific level. Targeting multiple signaling pathways is often required to prevent resistance to chemotherapy in cancer [4] . Identification of defects in cell signaling pathways is essential for understanding the molecular basis of human diseases [1] [2] [3] [4] .
The complexity of signaling pathways arises from the diverse ways protein interactions connect between signaling molecules to regulate gene expression. Several protein interaction databases such as STRING, BIOGRID, and WIKI-PI were developed [5] [6] [7] . Furthermore, differential mRNA levels of signaling molecules in a tissue or cell-specific fashion in normal and pathological conditions were also reported in databases such as Gene Expression across Normal and Tumor tissue (GENT), Renal Gene Expression Database (RGED) and Lung Cell Transcriptome Explorer [8] [9] [10] [11] . The main objective of this paper is to gain insights into the mammalian signaling pathways by pairwise comparison of protein interaction partners of critical signaling hubs in multiple related signaling pathways. In addition, analysis across several hubs in related pathways might reveal critical nodes and modules involved in cell signaling. It is clear from protein interaction databases that co-operative transcription factors generally share a large number of common protein interaction partners (5) (6) (7) . Furthermore, these transcription factors also share a large number of common target genes. Identification of common signaling molecules between two signaling hubs and organizing them into a concise interaction network allows for visualizing the critical connections. Critical nodes and modules across signaling hubs were determined by functional data analysis of candidates in various databases from knockout, knockdown or overexpression studies. This approach might reveal modules of functional connectivity across several signaling hubs in related signaling pathways and provide potential targets to simultaneously activate or inhibit gene expression.
Methods
All entries of protein interaction partners of signaling hubs in this paper were retrieved from WIKI-PI, a human protein-protein interaction database [7] . It is worth pointing out that protein interaction databases differ in the list of interaction partners for each entry based on criteria like in vitro or in vivo detection and methodologies such as immunoprecipitation, co-expression or yeast 2-hybrid interaction analysis [5] [6] [7] . They also differ in the number of model organisms included on their list. Schematic representations of cytokine signaling ( Figure 2 ) were modified from previously published reviews [12] [13] [14] . Tissue expression data for BRCA1, MYC, NOTCH1, and FBXW7 were obtained from Gene Expression across Normal and Tumor tissue (GENT) database [8] . Relative mRNA expression levels of BRCA1 and TSC22D3 in control and dexamethasone treated small airway epithelial cells of human donors were retrieved from the database [11] . Read counts of each gene in the database were obtained by HTSeq and differential expression results were obtained by DESeq2.
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2.2
Protein Interactions Connectome-Venn (PIC-VENN) method of signaling hubs
In the protein network analysis, interaction partners of signaling hubs S1 and S2 were considered. The overlapping area is V, for "Venn" that includes the elements that are in both sets. This relationship can be expressed in terms of an overlapping set as shown in a Venn diagram ( Figure 1 ). The PIC-VENN method consists of three steps. First, Microsoft Excel software was used to construct a simple Venn diagram of common interaction partners by pairwise comparison of critical signaling hubs. Briefly, protein interaction partner lists of the two signaling hubs were analyzed for duplicate values in the Excel program that correspond to common interaction partners of the signaling hubs. In Step 2, a network diagram of common interaction partners of the hubs together with the critical signaling hubs was visualized in BIOGRID tool Ensign (Human Mine) or the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database. The interacting proteins or nodes were represented by circles andprotein interactions by lines or edges in the network. In step 3, novel or critical node was selected from the common interaction partners by determining the biological effect of a node on the signaling pathway from knock out or over expression studies (from National Center for Biotechnology Information/ Pubmed query) or from differential expression in a disease-specific gene expression databases such as
GENT, Renal Gene Expression Database (RGED) and Lung Cell Transcriptome Explorer (LCTE).
Databases such as Gene cards (www.genecards.org) and mouse genome informatics (www.mgi.org) also provide concise information on entries related to human and mouse genes for critical node analysis, respectively.Two or more signaling hubs connected together with a critical node was designated as a signaling module.
Results and Discussion
STAT, NF-kB and AP1 family of transcription factors as critical hubs in innate and adaptive immunity
Cytokines such as Interferons (IFN), Tumor necrosis factor (TNF-), Interleukin-1 (IL-1) and
Interleukin-6 (IL-6) play an important role in innate immunity [19] [20] [21] . Dendritic cells and macrophages of innate immunity patrol various tissues and produce significant amounts of these cytokines in response to virus infection [21] . In contrast, CD8 + T cells play an important role in antiviral defense, tumor suppression and in the control of immunopathology in adaptive immunity [22, 23] . After engagement of the T cell receptor (TCR) by an appropriate antigen-major histocompatibility complex (MHC) on a target cell, activated CD8 + T cells produce pro-inflammatory cytokines such as TNF- and IFN- [23] .
These cytokines activate multiple transcription factors that bind to specific DNA sequences or ciselements to regulate gene expression. Transcriptional regulatory elements in eukaryotes are predominantly located within 1 kilobase [kb] of the transcription start site [24, 25] . were again highly represented ( Figure 2C ). These results suggested that transcriptional targets and biological functions of innate and adaptive immunity were associated with these three classes of transcription factors. Target genes of signaling hubs of innate and adaptive immunity such as RELA, STAT1 and JUN also share regulation by a common transcription factor network that includes SP1, STAT3, IRF1, FOS, TP53, HIFA, CREB1 and MYC suggesting that functional connectivity is mediated by common protein-protein interactions and target genes ( Figure 3 ).
3.2
Case study 1. Application of PIC-VENN to STAT1, STAT3, RELA and JUN hubs
To determine the common interaction partners of these transcription factors, pairwise comparison of critical signaling hubs was performed. Venn diagrams of STAT1 versus RELA, STAT1 versus STAT3 and STAT1 versus JUN indicated that there were 14, 13 and 12 common interactions between the hubs, respectively. Furthermore, comparison of common interacting partners across the hubs revealed that Breast Cancer Gene or BRCA1 emerged as one of the critical components of these signaling hubs ( Figure 4A ). Network analysis using BIOGRID program eSYN showed that BRCA1 emerged as a node linking RELA, STAT1, and JUN. Protein interactions identified by genetic analysis in the network were shown in green lines and BRCA1 node was highlighted in yellow color. In addition, a module consisting of STAT1, BRCA1, JUN and RELA can be identified across the hubs in pathways ( Figure 4B ). PIC-VENN results of common interaction partners can be used to search for biological significance in disease-specific expression array databases. Mutations in BRCA1 are common in breast and ovarian cancers [28, 29] . Comparison of BRCA1 expression in normal and tumor tissues revealed differential expression in cancers, especially blood cancers ( Figure 5A ). In addition, cancer cell lines of the blood including lymphoma and myeloma express high level of BRCA1 (data not shown). These results suggest that BRCA1 is a novel and critical node and mutations as well as abnormal level of BRCA1 expression in cells of immune origin may play an important role in cancer. BRCAI is a multifunctional protein with critical roles in cell cycle, DNA repair and tumor suppression [28] . BRCA1 target genes include several transcription factors such as STAT1 and STAT3 involved in immunity as well as TP53, MYC and HIF1A involved in cell growth suggesting that BRCA1 regulates multiple feedback loops that are involved in maintaining cellular homeostasis ( Table 1 ). The target genes of BRCA1 also included IRF7 that plays an important role in interferon signaling as well as production of type I interferon [30] .
BRCA1 functions in the transcription control of gene expression by interacting with specific transcription factors like TP53, ER alpha and MYC [31] . BRCA1 also interacts with RNA polymerase holoenzyme complex, histone acetyl transferases such as CBP/p300 and histone deacetylases such as HDAC that regulate nucleosome assembly and disassembly [31, 32] . In addition, BRCA1 interacts with DNA methyl transferases and functions as E3 ubiquitin ligase to regulate epigenetic mechanisms such as methylation and ubiquitination [31] . PIC-VENN studies suggest that BRCA1 may have a major role in modulating cytokine signaling and a critical role in innate and adaptive immunity. BRCA1 modulates IFN- signaling by specifically binding to STAT1 after phosphorylation on serine 727 residue [33] . This serine phosphorylation of STAT1 was highly enhanced in response to synergistic combination of IFN- with a variety of cytokines such as TNF- and IL-1 as well as bacterial cell wall component LPS induced inflammatory gene expression [34, 35] . IFN- caused a decrease in cell proliferation due to apoptosis in cells expressing wild type BRCA1 and mediated by an upregulation of type I IFN production [30, 36] . BRCA1 was recently identified as a nuclear co-factor to IFI16 in the sensing of foreign DNA and subsequent cytoplasmic inflammasome formation and secretion of antiviral cytokines such as IL-1 and IFN- [37] . STAT3 and RELA signaling hubs share 20 common interaction partners.
In addition, BRCA1 emerged as a critical node for the RELA-STAT3-JUN-STAT1 module ( Figure 5B ).
STAT3 and RELA share about 50 target genes including cytokines, chemokines, matrix metalloproteases and regulators of cell growth and apoptosis (data not shown). Recent studies have shown that cytokines that predominantly activate STAT3 and RELA such as IL-6 and TNF- in combination promote differentiation of human monocytic myeloid-derived suppressor cells (MDSC) into inflammatory macrophages [38] . These results are consistent with a role for BRCA1 in inflammation, in addition to its well-recognized roles in transcription, cell cycle and DNA repair [32] .
Furthermore, BRCA1 also emerged as a critical node in a pairwise comparison of RELA vs JUN or STAT3 vs JUN signaling hubs (data not shown). Treatment with dexamethasone, a synthetic glucocorticoid receptor agonist suppressed BRCA1 mRNA levels in human airway epithelial cells ( Figure 5C ).
IFN- is involved in the amplification of the inflammatory response by synergy in signaling with endotoxin, TNF and IL-1 and this synergy further enhances the severity of inflammatory response in sepsis [23, 34, 35] . Collaboration of multiple cis-elements and altered dimer composition of these three classes of transcription factors leading to cross-talk between signal transduction pathways may play an important role in the diversity of gene expression by transcriptional synergy or antagonism.
Case study 2. Application of PIC-VENN to AP1 and NF-KB signaling hubs
In addition to inflammatory response, members of NF-KB and AP1 transcription factors are also activated by diverse stimuli such as cell growth, DNA damage and apoptosis [3, 27] . A pairwise comparison of interaction partners of signaling hubs (FOS versus RELA, JUN versus NFKB1 and FOS versus JUN) revealed that these three sets also share a small number of interaction partners within the hubs and across the hubs ( Table 2) Figure 6A and 6B). Consistent with this prediction, functional studies have revealed that TSC22D3 interacts with NF-KB and AP1 and negatively regulated its function [39, 40] . AP1 and NF-KB member connections to negative regulators of signaling such as BCL3 and ATF3 were also highlighted ( Figure 6A ).
Interestingly, dexamethasone treatment significantly induced TSC22D3 mRNA levels in human airway epithelial cells ( Figure 6C ).
3.4
Case study 3. Application of PIC-VENN to JAK Kinases in Interferon Signaling
JAK Kinases are critical signaling hubs in growth factor and cytokine signaling including interferon responses [13, 26] . Virus infected cells produce different forms of interferons that serves as a danger signal to the neighboring cells to establish an antiviral response [20] . Dendritic cells and macrophages produce type I Interferon (IFN-) after virus infection [19] [20] [21] . In contrast, activated NK cells and CD8 + T cells produce type II Interferon or IFN- [22, 23] . JAK1 and TYK2 are activated in type I Interferon signaling while JAK1 and JAK2 are activated in type II Interferon signaling [26] . Interferon binds to a specific and distinct receptor on the cell surface and activate JAK-STAT pathway. This pathway is involved in the transcriptional regulation of several hundred genes [13] . Several Stat1independent pathways are also activated simultaneously, including extra-cellular signal regulated kinase (ERK1/2), SAPK members such as P38, phosphatidylinositol-3 kinase (PI-3K) and SRC kinases [41, 42] . The role of JAK kinases in tyrosine phosphorylation and creation of docking site and activation of STAT signaling is well established [13] . The role of additional tyrosine phosphorylation sites on the IFN receptor and JAK Kinase interaction partners involved in alternative signaling pathways might play a role in Stat1-independent IFN signaling remains to be established [41, 42] . However, limited information is available on JAK kinase interacting protein partners involved in these alternative pathways. Application of PIC-VENN revealed that JAK1 and TYK2 share 16 common interaction partners and JAK1 and JAK2 share 44 interaction partners. In addition, type I and type II IFN signaling share 11 common interaction partners ( Table 3 ). JAK1 and JAK2 common interaction network is large and visualized into two separate sub-networks with roles in IFN- and growth factor signaling ( Figure   7A and 7B). Common network interaction partners highlight the role of JAK1 and JAK2 in STAT1 and STAT3 activation as well as P-I-3-kinase and RAF1 involvement in AKT1 and ERK1/2 activation, respectively [41] . Analysis of protein interaction network suggested a novel connecting module of P-I- and across the signaling hubs in to a pathway in different databases helps to appreciate the similarities and differences between the signal transduction pathways. Therefore, network visualization of common interaction pathways in different databases might be useful to gain novel insights into signaling networks.
Case 4. Application of PIC-VENN for elucidation of signal transduction pathways and potential targets involved in disease conditions
Sepsis and septic shock represent the pathological response to infection [14] . Cytokines such as
Interferon- and TNF- as well as double-stranded RNA and bacterial LPS activate STAT1 and RNAdependent protein kinase (EIF2AK2 or PKR) signaling hubs in septic shock resulting in inflammatory response, apoptosis and tissue injury [52] [53] [54] . Apoptosis plays an important role in sepsis-induced mortality [53, 54] . One of the major control points in apoptosis is the sequential activation of Caspases [54] . Studies have indicated that serum from septic shock patients activated transcription factors such as STAT1, NF-kB and IRF1 as well as Caspases [55] . Pairwise comparison of STAT1 and EIF2AK2 signaling hubs interactions revealed that common interacting partners include CASPASE 3, CASPASE 7, STAT3, RAC1 and TYK2 suggesting that caspase activation and apoptosis are an important part of the acute inflammatory response (Table 4 ). STAT1 regulates the constitutive levels of Caspase expression [56] . JAK kinases such as TYK2 were shown to be required for the activation of STAT1 and EIF2AK2 in response to double-stranded RNA or Bacterial RNA [57] . Inhibition of EIF2AK2 attenuated inflammatory response, blocked apoptosis and improved mortality in a mouse model of acute lung injury [53] . The network diagram of common interaction partners highlighted these experimentally validated results ( Figure 8A ). Interaction network visualization also suggested that RAC1 and STAT3 interaction might be important for critical nodes STAT1 and EIF2AK2 to form a module involved in the regulation of inflammatory response and disease [58, 59] . Acute inflammation is a hallmark of high mortality in pathogen response while chronic inflammation is a characteristic feature of many inflammatory diseases including cancer [60] . Cancer development involves alteration of signal transduction pathways leading to constitutive activation of oncogenes or loss of tumor suppressors implicated in the cell cycle regulation. In addition, several studies have shown that two hits in these critical genes are required to initiate cancer [4, 61] . All cancers share some molecular features referred to as hallmarks such as self-sufficiency in growth signals, loss of response to inhibitory growth signals, ability to evade programmed cell death or apoptosis and unlimited replication potential [62] . Molecular defects in cancer are heterogeneous. It is important to understand the critical signaling hubs and interaction partners perturbed in individual signaling pathways in order to achieve the goals of personalized medicine [1, 2, 4] , Targeting common interaction partners of two signaling hubs in a signal transduction pathway may enhance chemotherapy in cancer ( Table 4 ). The following examples include using PIC-VENN to target transcription factors or kinases or both in various cancers. STAT3 and AKT1 constitute potent survival signals for cancers and are constitutively activated in a variety of cancers [63] .
These two signaling hubs share 9 interaction partners including the module containing critical nodes SRC and MTOR Kinases ( Figure 8B ). Furthermore, inhibition of these Kinases can be used in combination to target both pathways in some cancers [64] . Two Serine Kinases STK39 and AKT1 share the same interaction Protein Kinase, p38 or MAPK14 (Table 4 ). Consistent with a critical function of MAPK14 in cancer, inhibition of the STK39 by antisense approach stabilized microtubules, inhibited cell cycle progression and induced apoptosis. This effect was mediated by inhibition of MAPK14 phosphorylation and enhanced paclitaxel sensitivity of ovarian cancer [65] . Constitutive activation of transcription factors MYC or NOTCH1 occurs in a variety of cancers [66] . These two signaling hubs share 6 interaction partners, including FBXW7 ( Figure 8C ). Comparing the expression levels of two signaling hubs and a common interaction partner in the normal and cancer tissue database provided clues on the role of this pathway in a particular type of cancer (Figure 9 ). MYC and NOTCH1 as well as common interactor FBXW7 expression levels were significantly altered in several cancers, especially in blood cancers [67] . Consistent with the results, mutations in FBXW7 were reported in 2-6% of chronic lymphocytic leukemia (CLL) resulting in the activation of NOTCH11 intracellular domain (NCID) and MYC target genes [68] . Network visualization also revealed that RELA, GSK3B
components of the module might regulate these critical developmentally regulated genes ( Figure 8C ).
Negative results such as lack of common interaction partners between two signaling hubs can also be informative suggesting that inhibitors for both hubs can be combined into a single chemotherapy.
Conclusions and Perspectives
In summary, signaling hubs in simultaneously activated signaling pathways share a large number of common interaction partners and target genes involved in a common biological function suggesting that structural connectivity translates into functional connectivity of common interaction partners. PIC-VENN provides significant information on critical nodes and modules when the analysis is carried out across 3 or more pairs of signaling hubs in related signaling pathways (Figures 4 and Figure 6 ). Even a comparison of two critical signaling hubs provides some useful information on novel nodes and modules (Figure 8 ). Algorithms such as Google PageRank and Eigenvector Centrality might be helpful in the prediction and ranking of critical nodes from the analysis of gene perturbation data in the future. Small molecules such as dexamethasone can be used to target critical nodes such as BRCA1 and TSC22D3 to simultaneously activate or inhibit multiple target genes.
The common protein interaction connectome analysis of critical signaling hubs by PIC-Venn approach is conceptually similar to the identification of shared genes and signal transduction pathways in a comparative study of multiple sclerosis and in response to interferon beta treatment [69] . However, this method was applied to genome-wide analysis (GWAS) of a disease and not critical signaling hubs as detailed in this report. Human protein interaction miner (HPIminer) is a protein interaction database that allows combined view of common and unique interacting proteins of signaling hubs in a Cytoscape program [70] . The entries were curated from Human Protein Reference Database (HPRD). Direct as well as indirect interactions between signaling hubs were also displayed. However, it is difficult to follow or identify unique patterns between hubs or across several hubs when large number of common interactions are involved. Furthermore, the database is limited to human proteins and does not allow for custom building of selective common interactions into a network. In contrast, PIC-VENN method can be used for multiple species and elucidation of novel or critical nodes and modules. A major disadvantage of many protein interactome studies is that they provide a snapshot of expression profile in cells or tissues at a particular time. However, it is well known that protein interactions and gene expression are dynamically and temporally regulated during cellular signaling. Further studies are required to systematically perturb protein interaction network to understand the role of individual nodes and modules in the dynamic nature of signal transduction pathways [71] . The impact of microbiome and its products such as small molecules and small proteins on the regulation of mammalian signal transduction pathways also remains to be investigated [72] . 3279-3283.
Table1. BRCA1 target genes common between RELA, STAT1, STAT3 and JUN
-regulated genes [highlighted in pink]
RELA STAT1  STAT3  JUN  CCND1  CCND1  CCND1  CDKN1A CDKN1A CDKN1A CDKN1A  CYP19A1  CYP19A1 CYP19A1  DDIT3  DDIT3  EGFR  EGFR  EGFR  EGFR  MYC  MYC  MYC  VEGFA  VEGFA  VEGFA  HIF1A  HIF1A  IFNA1  IFNA1  IRF7  IRF7  TFF1  TFF1  STAT1  STAT1  STAT3  STAT3  JAK2  JAK2  KRT17  KRT17  CXCL1  STAT2  TP53  CYP1A1  MDC1  SIRT1  FOS  EGR1 CDKN1B BRCA2 CCNB1 Table 2 NFKB1  FOS  FOS  VS JUN  VS RELA VS JUN  AR  CARM1  ATF2  ATF3  ATF3  BCL3  BCL3  BRCA1  CREBBP  CREBBP  COPA5  EEF1D  BATF  ELF3  JUN  ATF4  EP300  KDM2A  CEBPE  ESR1  MAP3K7  CEBPG  NCOA3  NCOA3  FOS  CREB5  GSK3B  COPS4  HMGA1  CSNK2A1  CSNK2A1  IKBKB  CSNK2A2  CSNK2A2  NCOA1  NCOA1  NCOA6  NCOA6  NCOA6  NCOR2  NCOR2  NCOR2  NR3C1  PML  GTF2  PPARG  PRKACA  MAF  PPP4C  SIRT1  MAFB  NFKB1  MAPK1  SP1  UBE2D1  NACA  UBE2L3  ETS2  STAT3  USF2  NCOA2  TRIP4  DDIT3  ETS1  ETS1  APP  NELFB  RB1  RELA  RELA  RPS6KA2  RUNX1,2  SMAD3  SMAD3  SMARCD1  SPI1  SPI1  STAT1  STAT1  SUMO1,2,3,4  TBP  TBP  TAF1  TAF1  TSC22D3  TSC22D3  TSC22D3  UBE2L  VDR  Table 3 SP1  STAT3  IRF1  FOS  TP53  HIF1A  CREB1  MYC  PPARG  CEBPA  STAT6   RELA   0   10   20   30   40   50   60   70   RELA  NFKB1  STAT1  SP1  STAT3  IRF1  FOS  TP53  HIF1A  CREB1  MYC  PPARG  CEBPA 
. Shared common interaction partners across NF-KB and AP1 Signaling hubs
. Common interaction partners of JAK kinases in Interferon signaling
